Skip to main content
. 2022 Sep 8;29(1):174–182. doi: 10.1158/1078-0432.CCR-22-1138

Table 3.

Outcomes at data cutoff.

N (%)
Treatment status 17
 Patients on treatment 7 (42)
 Patients off treatment 10 (59)
  Central nervous system (CNS) progressive disease 2 (12)
  Extracranial progressive disease 4 (24)
  CNS + extracranial progressive disease 1 (6)
  Radiation necrosis 1 (6)
  Adverse effect 1 (6)
  Patient choice 1 (6)
 Median months on treatment 8.9 (1.3–16.2)
Best extracranial response 11
 Complete response 0 (0)
 Partial response 5 (45)
 Stable disease 5 (45)
 Progressive disease 1 (5)
Best CNS response 15
 Complete response 0 (0)
 Partial response 11 (73)
 Stable disease 3 (20)
 Progressive disease 1 (5)
Best CNS response in active BCBM 10
 Complete response 0 (0)
 Partial response 7 (70)
 Stable disease 3 (30)
 Progressive disease 0 (0)